"Antilymphocyte Serum" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Serum containing GAMMA-GLOBULINS which are antibodies for lymphocyte ANTIGENS. It is used both as a test for HISTOCOMPATIBILITY and therapeutically in TRANSPLANTATION.
Descriptor ID |
D000961
|
MeSH Number(s) |
A12.207.152.846.500.203 D12.776.124.486.485.114.573.203 D12.776.124.790.651.114.573.203 D12.776.377.715.548.114.573.203 D20.215.401.203
|
Concept/Terms |
Antilymphocyte Serum- Antilymphocyte Serum
- Antilymphocyte Serums
- Serum, Antilymphocyte
- Serums, Antilymphocyte
Antilymphocyte Globulin- Antilymphocyte Globulin
- Antilymphocyte Globulins
- Globulin, Antilymphocyte
- Globulins, Antilymphocyte
Antithymoglobulin- Antithymoglobulin
- Antithymoglobulins
- Antithymocyte Globulin
- Antithymocyte Globulins
- Globulin, Antithymocyte
- Globulins, Antithymocyte
- Lymphocyte Immune Globulin, Anti-Thymocyte Globulin
- Lymphocyte Immune Globulin, Anti Thymocyte Globulin
- Anti-Thymocyte Globulin
- Anti Thymocyte Globulin
- Anti-Thymocyte Globulins
- Globulin, Anti-Thymocyte
- Globulins, Anti-Thymocyte
Antilymphoblast Globulins- Antilymphoblast Globulins
- Antilymphoblast Globulin
- Globulin, Antilymphoblast
- Globulins, Antilymphoblast
Antilymphocyte Immunoglobulin- Antilymphocyte Immunoglobulin
- Antilymphocyte Immunoglobulins
- Immunoglobulin, Antilymphocyte
- Immunoglobulins, Antilymphocyte
|
Below are MeSH descriptors whose meaning is more general than "Antilymphocyte Serum".
Below are MeSH descriptors whose meaning is more specific than "Antilymphocyte Serum".
This graph shows the total number of publications written about "Antilymphocyte Serum" by people in this website by year, and whether "Antilymphocyte Serum" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
Year | Major Topic | Minor Topic | Total |
---|
1995 | 0 | 2 | 2 |
1996 | 0 | 1 | 1 |
1999 | 1 | 0 | 1 |
2003 | 0 | 1 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Antilymphocyte Serum" by people in Profiles.
-
Study protocol: Minimum effective low dose: anti-human thymocyte globulin (MELD-ATG): phase II, dose ranging, efficacy study of antithymocyte globulin (ATG) within 6 weeks of diagnosis of type 1 diabetes. BMJ Open. 2021 12 07; 11(12):e053669.
-
Risk factors for BK polyomavirus nephritis in renal allograft recipients. Clin Transplant. 2004 Aug; 18(4):456-62.
-
Pseudotumor cerebri in idiopathic aplastic anemia. J AAPOS. 2003 Feb; 7(1):71-4.
-
Acquired pure megakaryocytic aplasia report of two cases with long-term responses to antithymocyte globulin and cyclosporine. Am J Hematol. 1999 Oct; 62(2):115-7.
-
How many endomyocardial biopsies are necessary in the first year after heart transplantation? Transpl Int. 1996; 9(3):243-7.
-
Induction therapy with cyclosporine without cytolytic agents results in a low incidence of acute rejection without significant renal impairment in heart transplant patients. Clin Transplant. 1995 Aug; 9(4):334-9.
-
Failure of intrathymic inoculation of donor-specific splenocytes to prolong cardiac or renal allograft survival in dogs. Transpl Immunol. 1995 Mar; 3(1):39-44.
-
The effect of host liver damage, portacaval shunt, and various immunosuppressive regimes on canine auxiliary liver transplantation. Transplantation. 1972 Aug; 14(2):175-82.